The high cost of health care-associated infections (HAIs), a growing incidence of antibiotic-resistant organisms, public reporting of hospital infection rates, and pay-for-performance initiatives that limit payments for HAIs, are all fueling continued demand for diagnostic and infection control products as health care providers look for ways to decrease the incidence and mortality of HAIs.
It has been more than a decade since the Institute of Medicine (IOM) published its landmark report, “To Err Is Human,” which helped bring medical errors and patient safety to...